Chinese asset manager Yinhua Fund Management has launched a new ETF providing exposure to innovative China A-share companies operating in certain technology-related industries.
The Yinhua CSI Research Innovation 100 ETF (159987 CH) has listed on Shenzhen Stock Exchange (SZSE) and comes with a management fee of 0.30%.
The fund tracks the CSI Innovation 100 Index which selects its constituents from the parent CSI All Share Index, a representation of the total China A-share market.
A-shares are Mainland-listed, renminbi-denominated stocks that trade on either the Shanghai and Shenzhen stock exchanges. The parent index includes all China A-shares that have been trading for at least three months.
The methodology uses the CSI Industry Classification System (CICS) to select firms from technology-related industries including information technology, telecommunication services, aerospace & defense, healthcare, automobiles & components, amongst others.
Stocks that rank in the bottom 20% by three-month and twelve-month liquidity are excluded. Any company that has an average R&D intensity (research and development expenditure dividend by sales) over the past two years that is less than 5% is also removed.
The remaining stocks are then ranked according to three equally-weighted factors (market capitalization, revenue, and gross margin). The index selects 100 securities from amongst the highest-ranked stocks while adhering to sector constraints.
Constituents are weighted by float-adjusted market capitalization subject to a single stock cap of 10%. Reconstitution and rebalancing occur semi-annually.
The index is presently primarily exposed to three sectors: information technology (39.7%), healthcare (24.9%), and industrials (23.4%) with lesser weights in telecommunication services (7.5%) and consumer discretionary (3.8%).
Jiangsu Hengrui Medicine is the largest constituent with a weight of 12.0%, followed by Hangzhou Hikvision Digital Technology (5.3%), Sany Heavy Industry (3.8%), East Money Information (3.3%), and ZTE (3.3%).